Furthermore, an inhibitor of DPP-4, teneligliptin has been shown to significantly attenuate ox-LDL uptake and foam cell formation of macrophages isolated from obese T2D mice and patients partly by suppressing CD36 and ACAT-1 expression [14]. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.